Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8143
Reference
MSAN(2024)24
Name
Pancreatic enzyme replacement therapy (PERT)
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Supplies
Drug Shortages
Description
Creon® 10,000 and 25,000 gastro-resistant capsules are in limited supply until 2026.
Nutrizym® 22 capsules are out of stock until mid-August 2024.
Pancrex V® capsules and powder remain available but are unable to support an increase in demand.
Unlicensed supplies of Creon® 10,000 and 25,000 gastro-resistant capsules and alternative brands of PERT may be sourced, lead times vary.
Clinical advice has been issued by several professional bodies to support the management of patients in light of these shortages.
Contact Name
Contact Email
Contact Address
Created
2024-05-13 13:13:52
Click to go back to homepage